Total Payments
$4,772
2024 Payments
$172.02
Companies
18
Transactions
254
Medicare Patients
898
Medicare Billing
$22,300
Payment Breakdown by Category
Food & Beverage$4,686 (98.2%)
Education$86.02 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,686 | 241 | 98.2% |
| Education | $86.02 | 13 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,135 | 67 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,059 | 65 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $827.95 | 27 | $0 (2024) |
| Amgen Inc. | $435.93 | 27 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $351.86 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $232.36 | 24 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $217.13 | 14 | $0 (2018) |
| Amarin Pharma Inc. | $135.23 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $125.88 | 4 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $54.44 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $172.02 | 7 | Novartis Pharmaceuticals Corporation ($152.76) |
| 2023 | $218.66 | 12 | Novartis Pharmaceuticals Corporation ($197.66) |
| 2022 | $256.26 | 15 | Novartis Pharmaceuticals Corporation ($157.02) |
| 2021 | $111.01 | 6 | Novartis Pharmaceuticals Corporation ($76.97) |
| 2020 | $102.50 | 1 | Janssen Pharmaceuticals, Inc ($102.50) |
| 2019 | $510.66 | 14 | SANOFI-AVENTIS U.S. LLC ($209.20) |
| 2018 | $1,675 | 96 | Janssen Pharmaceuticals, Inc ($424.76) |
| 2017 | $1,726 | 103 | Janssen Pharmaceuticals, Inc ($470.08) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Cardiovascular | ||||||
| 06/07/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: Cardiovascular | ||||||
| 09/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 97 | 121 | $18,021 | $2,782 |
| 2022 | 2 | 101 | 128 | $17,790 | $3,007 |
| 2021 | 2 | 72 | 98 | $11,720 | $2,127 |
| 2020 | 6 | 628 | 712 | $55,043 | $14,385 |
Total Patients
898
Total Services
1,059
Medicare Billing
$22,300
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 45 | 46 | $14,163 | $2,328 | 16.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 52 | 75 | $3,858 | $453.62 | 11.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 47 | 48 | $13,964 | $2,520 | 18.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 54 | 80 | $3,826 | $486.71 | 12.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 30 | 31 | $8,619 | $1,696 | 19.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 42 | 67 | $3,101 | $430.81 | 13.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 37 | 39 | $8,124 | $2,364 | 29.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 308 | 374 | $9,734 | $2,329 | 23.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 43 | 43 | $8,428 | $2,179 | 25.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 32 | $2,328 | $1,638 | 70.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 53 | $7,115 | $1,419 | 19.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 37 | 37 | $4,974 | $1,400 | 28.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 21 | $4,092 | $1,050 | 25.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 18 | 18 | $3,528 | $960.38 | 27.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 19 | $3,938 | $703.79 | 17.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 74 | 76 | $2,782 | $339.96 | 12.2% |
About Dr. David Abisalih, MD
Dr. David Abisalih, MD is a Cardiovascular Disease healthcare provider based in Skowhegan, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710967153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Abisalih, MD has received a total of $4,772 in payments from pharmaceutical and medical device companies, with $172.02 received in 2024. These payments were reported across 254 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,686).
As a Medicare-enrolled provider, Abisalih has provided services to 898 Medicare beneficiaries, totaling 1,059 services with total Medicare billing of $22,300. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Skowhegan, ME
- Active Since 01/20/2006
- Last Updated 06/27/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1710967153
Products in Payments
- XARELTO (Drug) $1,052
- ENTRESTO (Drug) $965.85
- ELIQUIS (Drug) $740.03
- PRALUENT (Drug) $351.86
- Repatha (Biological) $307.35
- BRILINTA (Drug) $228.29
- PRADAXA (Drug) $182.93
- LEQVIO (Drug) $169.34
- Vascepa (Drug) $135.23
- Corlanor (Drug) $128.58
- PRALUENT ALIROCUMAB INJECTION (Biological) $76.70
- CAMZYOS (Drug) $64.89
- Definity (Drug) $54.44
- OPSUMIT MACITENTAN (Drug) $51.38
- JARDIANCE (Drug) $49.43
- PRALUENT (Biological) $49.18
- LifeVest (Device) $25.01
- VERQUVO (Drug) $21.70
- Veltassa (Drug) $10.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.